| Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility BP Howden, PB Ward, PGP Charles, TM Korman, A Fuller, P Du Cros, ... Clinical Infectious Diseases 38 (4), 521-528, 2004 | 606 | 2004 |
| Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis A Toczek, H Cox, P Du Cros, G Cooke, N Ford The International Journal of Tuberculosis and Lung Disease 17 (3), 299-307, 2013 | 211 | 2013 |
| Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis VB Rao, N Johari, P du Cros, J Messina, N Ford, GS Cooke The Lancet infectious diseases 15 (7), 819-824, 2015 | 162 | 2015 |
| Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses FA Khan, MAH Salim, P du Cros, EC Casas, A Khamraev, W Sikhondze, ... European Respiratory Journal 50 (1), 2017 | 120 | 2017 |
| A 24-week, all-oral regimen for rifampin-resistant tuberculosis BT Nyang’wa, C Berry, E Kazounis, I Motta, N Parpieva, Z Tigay, ... New England Journal of Medicine 387 (25), 2331-2343, 2022 | 115 | 2022 |
| Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS N Ford, K Singh, GS Cooke, EJ Mills, T von Schoen-Angerer, ... Clinical infectious diseases 54 (10), 1465-1472, 2012 | 99 | 2012 |
| Anthropology in public health emergencies: what is anthropology good for? D Stellmach, I Beshar, J Bedford, P Du Cros, B Stringer BMJ global health 3 (2), e000534, 2018 | 91 | 2018 |
| “Home is where the patient is”: a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis S Horter, B Stringer, L Reynolds, M Shoaib, S Kasozi, EC Casas, ... BMC health services research 14, 1-8, 2014 | 88 | 2014 |
| Principles for designing future regimens for multidrug-resistant tuberculosis G Brigden, BT Nyang'wa, P du Cros, F Varaine, J Hughes, M Rich, ... Bulletin of the World Health Organization 92, 68-74, 2013 | 87 | 2013 |
| Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis S Abidi, J Achar, MMA Neino, D Bang, A Benedetti, S Brode, JR Campbell, ... European Respiratory Journal 55 (3), 2020 | 70 | 2020 |
| Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study M Bonnet, M Bastard, P Du Cros, A Khamraev, K Kimenye, S Khurkhumal, ... The International Journal of Tuberculosis and Lung Disease 20 (2), 177-186, 2016 | 68 | 2016 |
| Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011 DJ Ulmasova, G Uzakova, MN Tillyashayhov, L Turaev, W Van Gemert, ... Eurosurveillance 18 (42), 20609, 2013 | 63 | 2013 |
| Risk factors associated with default from multi-and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysis MK Lalor, J Greig, S Allamuratova, S Althomsons, Z Tigay, A Khaemraev, ... PLoS One 8 (11), e78364, 2013 | 60 | 2013 |
| Off-label use of bedaquiline in children and adolescents with multidrug-resistant tuberculosis J Achar, C Hewison, AP Cavalheiro, A Skrahina, J Cajazeiro, P Nargiza, ... Emerging infectious diseases 23 (10), 1711, 2017 | 59 | 2017 |
| A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays A Penn-Nicholson, SN Gomathi, C Ugarte-Gil, A Meaza, E Lavu, P Patel, ... European Respiratory Journal 58 (5), 2021 | 51 | 2021 |
| Rapid differentiation of Candida albicans from non‐albicans species by germ tube test directly from BacTAlert blood culture bottles JA Terlecka, PA Du Cros, C Orla Morrissey, D Spelman Mycoses 50 (1), 48-51, 2007 | 51 | 2007 |
| The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa DP O'Brien, E Comte, M Serafini, G Ehounou, A Antierens, H Vuagnat, ... The Lancet infectious diseases 14 (5), 435-440, 2014 | 42 | 2014 |
| Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan S Horter, B Stringer, J Greig, A Amangeldiev, MN Tillashaikhov, ... BMC Infectious Diseases 16, 1-15, 2016 | 39 | 2016 |
| Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe L Benova, K Fielding, J Greig, BT Nyang'wa, EC Casas, MS da Fonseca, ... PloS one 7 (4), e35948, 2012 | 35 | 2012 |
| Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis LM Boak, J Li, D Spelman, P du Cros, RL Nation, CR Rayner Annals of Pharmacotherapy 40 (7-8), 1451-1455, 2006 | 35 | 2006 |
